1. Bridges, B.A., and D.G. Harnden, eds. (1982) Ataxia-Telangiectasia, a Cellular and Molecular Link between Cancer, Neuropathology, and Immune Deficiency, John Wiley and Sons, New York.
2. Inoue, T., K. Aikawa, H. Tezuka, T. Kada, and L.D. Shultz (1986) Effect of DNA-damaging agents on isolated spleen cells and lung fibroblasts from the mouse mutant “wasted,” a putative animal model for ataxia telangiectasia. Cancer Res. 46:3979–3982.
3. Inoue, T., H. Tezuka, T. Kada, K. Aikawa, and L.D. Shultz (1986) The mouse mutant “wasted,” an animal model for ataxia telangiectasia. In Antimutagenesis and Anticarcinogenesis Mechanisms, D.M. Shankel, P.E. Hartman, T. Kada, and A. Hollaender, eds. Plenum Press, New York, pp. 323–335.
4. Shultz, L.D., H.O. Sweet, M.T. Davisson, and D.R. Coman (1982) “Wasted,” a new mutant of the mouse with abnormalities characteristic of ataxia telangiectasia. Nature 297:402–404.
5. Tezuka, H., T. Inoue, T. Noguchi, T. Kada, and L.D. Shultz (1986) Evaluation of the mouse mutant “wasted” as an animal model for ataxia telangiectasia. I. Age-dependent and tissue-specific effects. Mutat. Res. 161:83–90.